A digital therapeutic component to optimize induction of buprenorphine-containing products

A digital and product technology, applied in the field of digital therapy, can solve the problems of high attrition rate, lack of drug attachment, limited effectiveness, etc.

Pending Publication Date: 2021-12-17
ペア セラピューティクス(ユーエス)インコーポレイテッド
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For those patients seeking OUD treatment, lack of drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A digital therapeutic component to optimize induction of buprenorphine-containing products
  • A digital therapeutic component to optimize induction of buprenorphine-containing products
  • A digital therapeutic component to optimize induction of buprenorphine-containing products

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029]Example embodiments are provided so that this disclosure will be thorough, and will fully convey the scope to those who are skilled in the art. Numerous specific details are set forth, such as examples of specific compositions, components, devices and methods, to provide a thorough understanding of embodiments of the present application. It will be apparent to those skilled in the art that specific details need not be employed, that example embodiments may be embodied in many different forms and that neither should be construed to limit the scope of the application. In some example embodiments, well-known processes, well-known device structures, and well-known technologies are not described in detail.

[0030] refer to figure 1 , in some embodiments, treatment prescribing system 100 provides patient 101 with access to prescribed digital therapeutics 120 prescribed to patient 101 and monitors events associated with patient 101 interactions with prescribed digital therape...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A system comprises data processing hardware and memory hardware in communication with the data processing hardware, the memory hardware storing instructions that when executed on the data processing hardware cause the data processing hardware to perform operations comprising executing a prescription digital therapeutic configured to treat symptoms associated with opioid use disorder in a patient, wherein executing the prescription digital therapeutic comprises receiving a plurality of inputs associated with the patient from one or more of (i) first sensors associated directly with the patient and (ii) second sensors associated with a patient electronic device, wherein the plurality of inputs represent a level of opioid withdrawal associated with the patient, weighting the plurality of inputs associated with the patient to provide a plurality of weighted inputs, determining a recommended dosage of a buprenorphine-containing product for the patient based on the plurality of weighted inputs, and instructing an administration unit to administer the recommended dosage of the buprenorphine-containing product to the patient.

Description

[0001] Cross References to Related Applications [0002] This US patent application claims priority under 35 U.S.C. §119(e) to US Provisional Application 62 / 779,705, filed December 14, 2018. The disclosure of the earlier application is considered part of the disclosure of the present application and is hereby incorporated by reference in its entirety. technical field [0003] The present disclosure relates to digital therapeutics, and more particularly to systems and methods for using digital therapeutics to improve adherence to and induction of medications, such as buprenorphine-containing products. Background technique [0004] The information provided in this section is for the purpose of generally presenting the context of this application. To the extent described in this section, the work of the presently named inventors and aspects of the presently named inventors that, at the time of filing, may not be consistent with the description of the prior art are neither expr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G16H20/10G16H50/20G16H10/60
CPCA61K31/485G16H40/63G16H20/17A61B5/0022A61B5/02444A61B5/4836A61B2562/0219A61B2562/0257A61B5/4833G16H20/13G16H50/20G16H20/10A61P25/04A61P25/36G16H80/00G16H10/60
Inventor 希拉里·路德勒尼科尔·恩曼奥黛丽·科恩杰克·尼克尔斯尤里·马里奇
Owner ペア セラピューティクス(ユーエス)インコーポレイテッド
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap